IMBRUVICA 140 mg, 280 mg, 420 mg and 560 mg film-coated tablets * Pharmacy Only: Prescription DHPC
Company:
Janssen Sciences IrelandStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
(Click to Download) IMBRUVICA® (ibrutinib): New risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events
Direct Healthcare Professional Communication (DHPC)